ArticleFrontiers in medicine2026

Gastrointestinal toxicity associated with cyclin-dependent kinase 4/6 inhibitors in breast cancer patients: insights from a real-world pharmacovigilance analysis.

Mengjiao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.